Agamree 40 mg/ml
As listed in the register: Agamree 40 mg/ml, Suspension zum Einnehmen
40 mg/ml ·
- Prescription only
- Hormones, such as thyroid and steroids
- Active substance
- Vamorolonum
- Made by
- Santhera Pharmaceuticals (Schweiz) AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Behandlung von Duchenne-Muskeldystrophie
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Santhera Pharmaceuticals (Schweiz) AG |
|---|---|
| Active substance | Vamorolonum |
| Used in | Hormones, such as thyroid and steroids |
| Strength | 40 mg/ml |
| Classification | H02AB18 · Hormones, such as thyroid and steroids |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Agamree 40 mg/ml, Suspension zum Einnehmen |
| Packs | 100 ml |
| Zulassungsnummer | 69650 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.